Rose C. and Nathan L. Milstein Family Emerging Scholar and Research Assistant Professor of Neurology Stephanie Eid, Ph.D., has quickly become a rising star in the field of neuropathy, since joining the NeuroNetwork for Emerging Therapies in 2019. This past year, Dr. Eid received the American Neurological Association’s (ANA) Wolfe Neuropathy Research Prize, the highest honor for a young researcher studying neuropathy.
Her long-term goal is to develop mechanism-based therapies that impact diabetic neuropathy before irreversible nerve damage occurs to significantly improve the quality of life of affected patients. Currently, she is the NeuroNetwork’s diabetes team leader, overseeing a group of five fellows and eight research technicians dedicated to alleviating the suffering of the neurological complications of diabetes through research.
Dr. Eid has attended and presented her research at PNS conferences since 2017, while she was still at the American University of Beirut. At the 2018 PNS Meeting, she co-chaired an oral Poster Presentations Session, entitled “Diabetic Neuropathy Consortium.”
Now, Dr. Eid seeks to use the skills honed throughout her academic career, most recently under the mentorship of Eva Feldman, M.D., Ph.D., to further help the PNS mission as a member of the board of directors. Those who work with Dr. Eid, believe she is uniquely positioned to improve the lives of people with peripheral neuropathies by supporting basic and clinical research, education, and standards of care in cooperation with patients and those developing treatments.
Why Dr. Eid? “My life experience as an immigrant, my expertise as a scientist, and my role as a mentor put me in a very strong position to give back to the field of neuropathy research and the PNS community as a whole,” she explains.